Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

The pharmaceutical powerhouse has two drugs that disrupt the transmission of the virus, one of which has been approved for ...

Wells Fargo analyst Mohit Bansal maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a price target of $140.00.

In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Gilead Sciences (GILD – Research Report), ...

With over seven years of experience in data science and analytics, Nidhi has led high-impact projects at leading healthcare ...